{
    "id": 28995,
    "fullName": "ERCC2 H659Y",
    "impact": "missense",
    "proteinEffect": "loss of function",
    "geneVariantDescriptions": [
        {
            "description": "ERCC2 H659Y lies within a highly conserved helical motif in the Ercc2 protein (PMID: 29980530). H659Y confers a loss of nucleotide excision repair (NER) activity to the Eccr2 protein, as demonstrated by the inability to rescue cells from cisplatin and ultraviolet sensitivity (PMID: 29980530).",
            "references": [
                {
                    "id": 12969,
                    "pubMedId": 29980530,
                    "title": "ERCC2 Helicase Domain Mutations Confer Nucleotide Excision Repair Deficiency and Drive Cisplatin Sensitivity in Muscle-Invasive Bladder Cancer.",
                    "url": "http://www.ncbi.nlm.nih.gov/pubmed/29980530"
                }
            ]
        }
    ],
    "type": null,
    "gene": {
        "id": 2068,
        "geneSymbol": "ERCC2",
        "terms": [
            "ERCC2",
            "COFS2",
            "EM9",
            "TFIIH",
            "TTD",
            "TTD1",
            "XPD"
        ]
    },
    "variant": "H659Y",
    "createDate": "11/25/2018",
    "updateDate": "11/25/2018",
    "referenceTranscriptCoordinates": {
        "id": 177631,
        "transcript": "NM_000400",
        "gDna": "chr19:g.45352577G>A",
        "cDna": "c.1975C>T",
        "protein": "p.H659Y",
        "sourceDb": "RefSeq",
        "refGenomeBuild": "GRCh38/hg38"
    },
    "partnerGenes": [
        
    ],
    "evidence": [
        {
            "id": 15258,
            "approvalStatus": "Preclinical - Cell culture",
            "evidenceType": "Actionable",
            "efficacyEvidence": "In a preclinical study, Platinol (cisplatin) decreased cell survival of transformed human fibroblasts expressing ERCC2 H659Y (PMID: 29980530).",
            "molecularProfile": {
                "id": 30916,
                "profileName": "ERCC2 H659Y"
            },
            "therapy": {
                "id": 700,
                "therapyName": "Cisplatin",
                "synonyms": null
            },
            "indication": {
                "id": 11054,
                "name": "urinary bladder cancer",
                "source": "DOID"
            },
            "responseType": "predicted - sensitive",
            "references": [
                {
                    "id": 12969,
                    "pubMedId": 29980530,
                    "title": "ERCC2 Helicase Domain Mutations Confer Nucleotide Excision Repair Deficiency and Drive Cisplatin Sensitivity in Muscle-Invasive Bladder Cancer.",
                    "url": "http://www.ncbi.nlm.nih.gov/pubmed/29980530"
                }
            ],
            "ampCapAscoEvidenceLevel": "D",
            "ampCapAscoInferredTier": "II"
        }
    ],
    "molecularProfiles": [
        {
            "id": 30916,
            "profileName": "ERCC2 H659Y",
            "profileTreatmentApproaches": [
                
            ]
        }
    ],
    "allTranscriptCoordinates": [
        {
            "id": 177631,
            "transcript": "NM_000400",
            "gDna": "chr19:g.45352577G>A",
            "cDna": "c.1975C>T",
            "protein": "p.H659Y",
            "sourceDb": "RefSeq",
            "refGenomeBuild": "GRCh38/hg38"
        },
        {
            "id": 177630,
            "transcript": "XM_017026467",
            "gDna": "chr19:g.45352301G>A",
            "cDna": "c.1975C>T",
            "protein": "p.H659Y",
            "sourceDb": "RefSeq",
            "refGenomeBuild": "GRCh38/hg38"
        }
    ]
}